Arthur J. Gallagher (AJG) Positioned For Organic Topline Growth
Muhammad Ali Khalid
Thu, February 19, 2026 at 2:08 PM GMT+9 2 min read
In this article:
StockStory Top Pick
AJG
+0.23%
Arthur J. Gallagher & Company (NYSE:AJG) is one of the 12 oversold financial stocks to invest in according to hedge funds.
On January 30, Paul Newsome from Piper Sandler maintained his Neutral rating on Arthur J. Gallagher & Company (NYSE:AJG). The analyst, however, reduced the price target from $272 to $249, which now leads to an upside potential of around 20%.
Copyright: sifotography / 123RF Stock Photo
Newsome acknowledged Arthur J. Gallagher & Company’s (NYSE:AJG) acquisition revenues and other items that led to “better-than-expected” profitability in the recent announcement. He noted management’s continued optimism about future organic topline growth. However, the analyst expressed his concerns on weakening business environment and ongoing competitive pressures.
On January 30, the price target on Arthur J. Gallagher & Company (NYSE:AJG) was lowered from $311 to $298 by Wells Fargo analyst Elyse Greenspan, who maintained an Overweight rating on the stock.
Greenspan’s revised projections offer an upside potential of 43%. She highlighted the company’s fourth quarter EPS of $2.38, which beat Wells Fargo’s $2.33 and the street’s $2.35 estimates due to higher Brokerage profitability margins. Organic growth across the Brokerage segment was reported at 5%.
Arthur J. Gallagher & Company (NYSE:AJG) delivers insurance brokerage, reinsurance, risk management, consulting, and third-party claims settlement services, covering both individuals and corporate clients. Some of its offerings include insurance placement, underwriting management, wholesale insurance, and reinsurance negotiating services. Through its operations, it caters to commercial, industrial, public sector, and non-profit clients.
While we acknowledge the potential of AJG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.
Disclosure: None. This article is originally published at Insider Monkey.
Terms and Privacy Policy
Privacy Dashboard
More Info
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Arthur J. Gallagher (AJG) Positioned For Organic Topline Growth
Arthur J. Gallagher (AJG) Positioned For Organic Topline Growth
Muhammad Ali Khalid
Thu, February 19, 2026 at 2:08 PM GMT+9 2 min read
In this article:
AJG
+0.23%
Arthur J. Gallagher & Company (NYSE:AJG) is one of the 12 oversold financial stocks to invest in according to hedge funds.
On January 30, Paul Newsome from Piper Sandler maintained his Neutral rating on Arthur J. Gallagher & Company (NYSE:AJG). The analyst, however, reduced the price target from $272 to $249, which now leads to an upside potential of around 20%.
Copyright: sifotography / 123RF Stock Photo
Newsome acknowledged Arthur J. Gallagher & Company’s (NYSE:AJG) acquisition revenues and other items that led to “better-than-expected” profitability in the recent announcement. He noted management’s continued optimism about future organic topline growth. However, the analyst expressed his concerns on weakening business environment and ongoing competitive pressures.
On January 30, the price target on Arthur J. Gallagher & Company (NYSE:AJG) was lowered from $311 to $298 by Wells Fargo analyst Elyse Greenspan, who maintained an Overweight rating on the stock.
Greenspan’s revised projections offer an upside potential of 43%. She highlighted the company’s fourth quarter EPS of $2.38, which beat Wells Fargo’s $2.33 and the street’s $2.35 estimates due to higher Brokerage profitability margins. Organic growth across the Brokerage segment was reported at 5%.
Arthur J. Gallagher & Company (NYSE:AJG) delivers insurance brokerage, reinsurance, risk management, consulting, and third-party claims settlement services, covering both individuals and corporate clients. Some of its offerings include insurance placement, underwriting management, wholesale insurance, and reinsurance negotiating services. Through its operations, it caters to commercial, industrial, public sector, and non-profit clients.
While we acknowledge the potential of AJG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.
Disclosure: None. This article is originally published at Insider Monkey.
Terms and Privacy Policy
Privacy Dashboard
More Info